-
WellmarkerBio receives approval for Phase I clinical trial from the Australian Therapeutic Goods Administration
prnasia
March 04, 2021
Wellmarker Bio announced that on February 23, 2021 the company received approval from the Australian Therapeutic Goods Administration (TGA) for a Phase I clinical trial using WM-S1-030, a targeted anti-cancer drug for colorectal cancer and progressive ...
-
Australian scientists detect cancer with gold plated nanoparticles
biospectrumasia
October 15, 2018
During the study, the researchers altered gold-coated nanoparticles using DNA to match the miRNA to be detected.
-
Scientists use nanoparticles to detect deep-tissue cancers
biospectrumasia
August 10, 2018
This technique has the potential to provide a low-invasive method of determining if breast cancer is present, as well as the form of breast cancer, without the need to take tissue samples via biopsy
-
Australian researchers invent tiny fibre optic probe
biospectrumasia
April 16, 2018
The miniaturised imaging and sensing probe has been developed to help study drug-induced hyperthermia.
-
Allergan to acquire Australian biotech startup Elastagen
biospectrumasia
February 11, 2018
Elastagen’s revolutionary technology is based on recombinant human tropoelastin, the precursor of elastin which is a key component of youthful skin
-
Australian researchers offer hope for bone cancer
biospectrumasia
July 04, 2017
The researchers tested a new type of treatment that specifically targets a protein called sclerostin, which in healthy bones is an important regulator of bone formation.